跳至主要内容
临床试验/CTRI/2025/04/085078
CTRI/2025/04/085078尚未招募不适用

Association Of Neutrophil Lymphocyte Ratio With Diabetic Retinopathy In Type 2 Diabetes Mellitus Patient In Tertiory Care Centre A Cross Sectional Study

Dr Swetha Mallika1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年6月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To assess if Neutrophil lymphocyte ratio can be used as an inflammatory marker In Diabetic Retinopathy in Type 2 Diabetic patients.

研究概览

简要总结

As often India is referred to as Diabetes Capital or Diabetes Hub of the world. So diagnosing diabetes at early stage and getting adequate management accordingly and preventing the micro and macrovascular complications from diabetes plays a crucial role. But as India is a Developing country, many people living in remote areas and small towns are not accessible for basic as well as advanced laboratory tools for diagnosing diabetic complications at earliest as possible. These microvascular complications attribute to substantial rise in mortality and reduction of quality of life in diabetics. The  Neutrophil Lymphocyte ratio is a simple and cost effective laboratory tool which can predict the prognosis and severity of diabetic retinopathy and can be used as a Screening tool in places with limited resources like India.

研究设计

研究类型
Observational

入排标准

年龄范围
25.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • All diagnosed type 2 diabetes mellitus patients admitting in medicine ward of Sir T Hospital Bhavnagar during the period.

排除标准

  • Acute and chronic infection conditions Drugs effecting neutrophil and lymphocyte counts Auto immune disorders Alcoholics Smokers.

结局指标

主要结局

To assess if Neutrophil lymphocyte ratio can be used as an inflammatory marker In Diabetic Retinopathy in Type 2 Diabetic patients.

时间窗: Baseline, After 4 Weeks.

次要结局

  • To assess if neutrophil lymphocyte ratio can be used as a predictive marker in diagnosing the severity of diabetic retinopathy.(9months)

研究者

发起方
Dr Swetha Mallika
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Swetha Mallika

Government medical college Bhavnagar

研究点 (1)

Loading locations...

相似试验